Sort
15,842 grants matching “pancreatic cancer”
Two phospho-compounds for pancreatic cancer prevention
$163,280Gerardo Guillermo Mackenzie · University Of California At Davis · R21 · FY2016 · CA
HDAC3 - a therapeutic target in PDA
$163,277Michael John Hayman · State University New York Stony Brook · R21 · FY2013 · CA
Targeting Telomerase in Pancreateic Cancer
$163,276Derek James Taylor · Case Western Reserve University · R21 · FY2014 · CA
Mechanisms of Dicumarol-Induced Cytotoxicity
$163,274Joseph J Cullen · University Of Iowa · R21 · FY2007 · CA
Loss of the Exocrine Pancreas Improves Glucose Tolerance and Insulin Secretion
$163,188Mohamed Saleh · University Of Pittsburgh At Pittsburgh · K08 · FY2024 · DK
Loss of the Exocrine Pancreas Improves Glucose Tolerance and Insulin Secretion
$163,188Mohamed Saleh · University Of Pittsburgh At Pittsburgh · K08 · FY2023 · DK
Loss of the Exocrine Pancreas Improves Glucose Tolerance and Insulin Secretion
$163,188Mohamed Saleh · University Of Pittsburgh At Pittsburgh · K08 · FY2025 · DK
Core C-Computational Core
$163,158Phillip Andrew Futreal · University Of Tx Md Anderson Can Ctr · P01 · FY2021 · CA
Core C-Computational Core
$163,156Phillip Andrew Futreal · University Of Tx Md Anderson Can Ctr · P01 · FY2023 · CA
Translational Research in GI Cancer
$163,133Dean E. Brenner · University Of Michigan At Ann Arbor · P50 · FY2013 · CA
A Model for Preclinical Biomarker Discovery in Pancreatic Ductal Adenocarcinoma
$163,080Eric Collisson · University Of California, San Francisco · K08 · FY2010 · CA
A Model for Preclinical Biomarker Discovery in Pancreatic Ductal Adenocarcinoma
$163,080Eric Collisson · University Of California, San Francisco · K08 · FY2012 · CA
A Model for Preclinical Biomarker Discovery in Pancreatic Ductal Adenocarcinoma
$163,080Eric Collisson · University Of California, San Francisco · K08 · FY2011 · CA
A Model for Preclinical Biomarker Discovery in Pancreatic Ductal Adenocarcinoma
$163,080Eric Collisson · University Of California, San Francisco · K08 · FY2013 · CA
A Model for Preclinical Biomarker Discovery in Pancreatic Ductal Adenocarcinoma
$163,080Eric Collisson · University Of California, San Francisco · K08 · FY2014 · CA
CORE F: FUNCTIONAL GENOMICS FACILITY
$163,066Brian Keith Dieckgraefe · Washington University · P30 · FY2008 · DK
Core A: Administrative Core
$163,018William G Hawkins · Washington University · P50 · FY2019 · CA
Investigation of Rabs and trafficking regulators roles in tumorigenesis
$163,015Christopher Westlake · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
IGF-II-Based Approach to Therapy for Pancreatic Cancer
$163,010Richard G. Macdonald · University Of Nebraska Medical Center · R21 · FY2015 · CA
Nuclear receptor LRH-1 in pancreatic cancer
$162,979Robert J Fletterick · University Of California, San Francisco · R21 · FY2011 · CA
Pilot Study of Pancreas Cancer &Diabetes Genes in CARET
$162,970University Of Washington · R21 · FY2005 · CA
Training the Next Generation of Surgeon-Scientists in Pancreatology
$162,955Masato Yamamoto · University Of Minnesota · T32 · FY2019 · DK
Diagnosis, Natural History, Management,tumor biology of Gastrinomas/PETs
$162,891Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Pharmacogenomics of a Cytidine Analogue, Gemcitabine
$162,882Liewei Wang · Mayo Clinic Rochester · K22 · FY2008 · CA
Targeted CSN5 inhibition in Pancreatic Cancer
$162,799Wayne S Zundel · Oregon Health & Science University · R21 · FY2010 · CA